Mechanistic investigations have shown that AOD 9604 increases 3-adrenergic receptor expression at the mRNA level, restoring receptor density in systems where lipolytic responsiveness is impaired
Low and elevated dose adjustments Low Dose: 1.6 mg total contains 1 mg GHK-Cu and 200 mcg each of BPC-157, TB-4, and KPV
All Rights Reserved
Confirm the chemical name, counterion, molecular formula, molecular-weight basis, HPLC purity, mass-spectrometry result, test date, sample amount, and finished-lot traceability
Archived from the original on October 16, 2012
a shift toward fat storage in adipose tissue